Using a paravertebral block during thoracic (VATS/RATS) surgery to reduce postoperative complications
Official title: Perioperative Paravertebral Block Reduces Postoperative Complications in Thoracic Surgery: An Observational Study
Run by Tongji Hospital · NCT07211529 · Data updated 2026-11-12
This study will try an intraoperative paravertebral block to see if it lowers postoperative complications in adults having VATS or RATS for lung or mediastinal procedures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Tongji Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | March 25, 2025 |
| Main results expected | May 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | October 8, 2025 |
| Trial ID | NCT07211529 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older scheduled for VATS or RATS (wedge resection, segmentectomy, lobectomy, or mediastinal surgery) who can give informed consent and are treated by anesthesiologists trained in ultrasound-guided PVB.
✕Probably not a fit
Patients converted to open thoracotomy, with prior ipsilateral thoracic surgery, who do not complete the planned surgery, or who are lost to follow-up are unlikely to receive benefit from participation or from study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study with retrospective and prospective components conducted at Tongji Hospital campuses, focusing on patients undergoing thoracic operations such as wedge resection, segmentectomy, lobectomy, or mediastinal surgery. Retrospectively, prior cases in which an intraoperative paravertebral block (PVB) was used will be analyzed for associations with postoperative complications. Prospectively, perioperative biomarkers (including MMP3, neutrophils, leukocytes, PCT, CRP) and clinical measures (pain and cough scores, time to first flatus and defecation) will be collected, with 30-day follow-up for postoperative complications. The study will correlate biochemical markers with clinical outcomes to explore potential prognostic relationships.
Why it matters
Potential benefit: If successful, using intraoperative paravertebral block could reduce postoperative complications and speed recovery after thoracic minimally invasive surgery.
How similar studies have gone: Prior randomized and observational studies have shown PVB reduces postoperative pain and opioid use and some suggest fewer pulmonary complications, but results vary and definitive evidence on complication reduction is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female participants aged 18 years or older. 2. Scheduled to undergo thoracic surgery via Video-Assisted Thoracoscopic Surgery (VATS) or Robotic-Assisted Thoracoscopic Surgery (RATS), including wedge resection, segmentectomy, lobectomy, or mediastinal surgery. 3. Signed informed consent obtained prior to study participation. - Exclusion Criteria: 1. Patients who refuse to provide informed consent. 2. Anesthesiologists who have not received training in ultrasound-guided paravertebral block (PVB-US). 3. History of ipsilateral thoracic surgery. 4. Conversion to open thoracotomy during the procedure. 5. Patients who did not complete the scheduled surgery due to disease progression or medical reasons. 6. Patients who are lost to follow-up or refuse postoperative follow-up. -
Where it's running
-
Tongji Medical College of HUST: Huazhong University of Science and Technology Tongji Medical College Tongji Hospital
Wuhan, Hubei, China Recruiting
Study contacts
- Principal investigator: Zhang qin Zhang — Huazhong keji daxue tongji yixue yuan fushu tongji yiyuan
- Study coordinator: Guo jiateng Guo
- Email: 18737552580@163.com
- Phone: 18737552580
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Boosting lung cancer screening for patients seen in the emergency department
This project will test whether giving eligible emergency department patients a facilitated referral plus text reminders helps more people get lung cancer screening.
-
Using portable dynamic chest X-ray in the ICU
This study is testing a new portable chest X-ray system in the ICU to see if it can give better pictures of lung movement and function compared to regular X-rays and CT scans for critically ill patients.
-
Lung perfusion scans in ED patients with suspected pulmonary embolism
This study looks at how lung perfusion (and sometimes ventilation) scans in adults with suspected pulmonary embolism seen in the emergency department influence clinical decisions and patient outcomes.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
AI-Personalized Discharge Education After Lung Cancer Surgery
This study tests whether an AI-generated, personalized discharge guide helps patients recover better after lung cancer surgery compared with standard discharge education.
-
Next Generation Delivery System (NGDS) for SBRT in thorax and upper abdomen
A study tests a new machine to deliver SBRT more quickly and comfortably for adults with thoracic or upper abdominal cancers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.